Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghadimi, B. M.
Right arrow Articles by Becker, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghadimi, B. M.
Right arrow Articles by Becker, H.
Clinical Cancer Research Vol. 9, 1808-1814, May 2003
© 2003 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Gain of Chromosome 8q23–24 Is a Predictive Marker for Lymph Node Positivity in Colorectal Cancer

B. Michael Ghadimi1, Marian Grade2, Torsten Liersch, Claus Langer, Alexander Siemer, László Füzesi and Heinz Becker

Department of General, Visceral, and Transplantation Surgery [B. M. G., M. G., T. L., C. L., H. B.], Institute of Pathology [L. F.], and Department of Medical Statistics [A. S.], University Medical Center Göttingen, 37075 Göttingen, Germany

Purpose: The prognosis of patients with colorectal cancer is largely determined by tumor stage. In this respect, colorectal cancers with lymph node metastases indicate a worse prognosis versus lymph node-negative tumors. Accordingly, there is considerable clinical interest in understanding the genetic mechanisms underlying metastasis formation. Furthermore, sensitive and specific biomarkers are needed to predict the metastatic phenotype at the time of diagnosis.

Experimental Design: Fifty colorectal cancers with or without lymph node metastases were assessed for genomic imbalances by comparative genomic hybridization. Particular interest was focused on whether specific chromosomal alterations exist in primary tumors that might be indicative and specific for the metastatic phenotype.

Results: The analysis revealed that lymph node-positive colorectal cancers show a higher degree of chromosomal instability than lymph node-negative cancers (average number of chromosomal copy alterations, 9.8 versus 7.5). Chromosomal alterations commonly described in colorectal cancers such as gain of 20q or loss of 18q21 were not different. However, the gain of chromosomal region 8q23–24 was seen in the vast majority of lymph node-positive cancers, whereas it was rather rare in lymph node-negative carcinomas (P = 0.0016).

Conclusions: These data suggest that genes located at 8q23–24 might favor the development of lymphatic metastases in colorectal cancers. Additionally, the gain of this region could be used to predict the metastatic potential of primary colorectal cancers.




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. Camps, M. Grade, Q. T. Nguyen, P. Hormann, S. Becker, A. B. Hummon, V. Rodriguez, S. Chandrasekharappa, Y. Chen, M. J. Difilippantonio, et al.
Chromosomal Breakpoints in Primary Colon Cancer Cluster at Sites of Structural Variants in the Genome
Cancer Res., March 1, 2008; 68(5): 1284 - 1295.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Grade, P. Hormann, S. Becker, A. B. Hummon, D. Wangsa, S. Varma, R. Simon, T. Liersch, H. Becker, M. J. Difilippantonio, et al.
Gene Expression Profiling Reveals a Massive, Aneuploidy-Dependent Transcriptional Deregulation and Distinct Differences between Lymph Node-Negative and Lymph Node-Positive Colon Carcinomas
Cancer Res., January 1, 2007; 67(1): 41 - 56.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Grade, B. M. Ghadimi, S. Varma, R. Simon, D. Wangsa, L. Barenboim-Stapleton, T. Liersch, H. Becker, T. Ried, and M. J. Difilippantonio
Aneuploidy-Dependent Massive Deregulation of the Cellular Transcriptome and Apparent Divergence of the Wnt/{beta}-catenin Signaling Pathway in Human Rectal Carcinomas
Cancer Res., January 1, 2006; 66(1): 267 - 282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Heselmeyer-Haddad, K. Sommerfeld, N. M. White, N. Chaudhri, L. E. Morrison, N. Palanisamy, Z. Y. Wang, G. Auer, W. Steinberg, and T. Ried
Genomic Amplification of the Human Telomerase Gene (TERC) in Pap Smears Predicts the Development of Cervical Cancer
Am. J. Pathol., April 1, 2005; 166(4): 1229 - 1238.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Bardi, C. Fenger, B. Johansson, F. Mitelman, and S. Heim
Tumor Karyotype Predicts Clinical Outcome in Colorectal Cancer Patients
J. Clin. Oncol., July 1, 2004; 22(13): 2623 - 2634.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.